JP2004520446A - ロサルタンカリウムの結晶化方法 - Google Patents

ロサルタンカリウムの結晶化方法 Download PDF

Info

Publication number
JP2004520446A
JP2004520446A JP2002591489A JP2002591489A JP2004520446A JP 2004520446 A JP2004520446 A JP 2004520446A JP 2002591489 A JP2002591489 A JP 2002591489A JP 2002591489 A JP2002591489 A JP 2002591489A JP 2004520446 A JP2004520446 A JP 2004520446A
Authority
JP
Japan
Prior art keywords
losartan
potassium
losartan potassium
acetone
alcohol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002591489A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004520446A5 (fr
Inventor
ラマシャンカル
レディ、ラヴィンダー、ヴェンナプ
シヴァクマラン、メーナクシスンデラム
ハンダ、ヴィジャイ、クマール
Original Assignee
オーロビンド ファーマ リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by オーロビンド ファーマ リミテッド filed Critical オーロビンド ファーマ リミテッド
Publication of JP2004520446A publication Critical patent/JP2004520446A/ja
Publication of JP2004520446A5 publication Critical patent/JP2004520446A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2002591489A 2001-05-18 2001-11-20 ロサルタンカリウムの結晶化方法 Pending JP2004520446A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN403CH2001 2001-05-18
PCT/IN2001/000205 WO2002094816A1 (fr) 2001-05-18 2001-11-20 Procede de cristallisation du losartan potassium

Publications (2)

Publication Number Publication Date
JP2004520446A true JP2004520446A (ja) 2004-07-08
JP2004520446A5 JP2004520446A5 (fr) 2005-02-17

Family

ID=11097003

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002591489A Pending JP2004520446A (ja) 2001-05-18 2001-11-20 ロサルタンカリウムの結晶化方法

Country Status (6)

Country Link
EP (1) EP1294712A1 (fr)
JP (1) JP2004520446A (fr)
BG (1) BG107478A (fr)
SI (1) SI21236A (fr)
SK (1) SK722003A3 (fr)
WO (1) WO2002094816A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030135041A1 (en) 2002-01-04 2003-07-17 Orchid Chemicals & Pharmaceuticals Limited, India Synthesis of ceftiofur intermediate
WO2004039352A2 (fr) * 2002-10-31 2004-05-13 Ranbaxy Laboratories Limited Forme amorphe de losartan potassium
ITMI20030328A1 (it) * 2003-02-25 2004-08-26 Dinamite Dipharma S P A In Forma A Bbreviata Diph Polimorfi di losartan potassio e procedimento per la loro preparazione.
WO2004076442A1 (fr) * 2003-02-28 2004-09-10 Ranbaxy Laboratories Limited Polymorphes de losartan
AU2003269470A1 (en) * 2003-04-03 2004-10-25 Ipca Laboratories Limited A process for the synthesis of losartan potassium
US7345071B2 (en) 2003-05-07 2008-03-18 Ipca Laboratories Limited Process for the synthesis of Losartan potassium
RS20060125A (en) * 2003-08-27 2008-06-05 Zentiva A.S., A method of removing the triphenylmethane protecting group
ITMI20032472A1 (it) * 2003-12-16 2005-06-17 Dinamite Dipharma S P A In Forma A Bbreviata Diph Procedimento per la preparazione di losartan potassio cristallino
EP1709034A2 (fr) * 2004-01-06 2006-10-11 IPCA Laboratories Limited Procede ameliore de synthese du losartan potassique
CA2555294A1 (fr) 2004-02-11 2005-08-25 Marina Yu Etinger Polymorphes de candesartan cilexetil
WO2005084670A1 (fr) * 2004-03-01 2005-09-15 Lek Pharmaceuticals D.D. Formulation pharmaceutique
KR20090029310A (ko) * 2004-05-05 2009-03-20 테바 파마슈티컬 인더스트리즈 리미티드 순도가 높은 칸데사르탄 실렉세틸의 제조
WO2010046804A2 (fr) * 2008-10-21 2010-04-29 Alembic Limited Procédé de préparation du losartan potassium forme i

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
DE69233734D1 (de) * 1991-11-18 2008-06-26 Du Pont 2-(2'-Triphenylmethyl-2'H-tetrazol-5'-yl)phenylborsäure als Zwischenprodukt zur Synthese von A II Receptorenantagonisten
DK0937068T3 (da) * 1996-10-29 2002-05-21 Merck & Co Inc Fremgangsmåde til krystallisation af losartan
HU222773B1 (hu) * 2000-04-21 2003-10-28 Richter Gedeon Vegyészeti Gyár Rt. Eljárás egy ismert tetrazolszármazék előállítására

Also Published As

Publication number Publication date
SI21236A (sl) 2003-12-31
BG107478A (bg) 2004-01-30
WO2002094816A1 (fr) 2002-11-28
SK722003A3 (en) 2003-12-02
EP1294712A1 (fr) 2003-03-26

Similar Documents

Publication Publication Date Title
JP5535082B2 (ja) ボセンタン、その多形形態及びその塩の合成方法
CA2793312C (fr) Forme i de lenalidomide anhydre
JP2020526476A (ja) オメカムティブメカルビルの合成
JP2010535742A (ja) オルメサルタンメドキソミルの調製または精製の方法
JP2004520446A (ja) ロサルタンカリウムの結晶化方法
JP2004520446A5 (fr)
US6710183B2 (en) Process for the synthesis of a known tetrazol derivative
EP1590343B1 (fr) Synthese de 2-butyl-3-(2'-(1-trityl-1h-tetrazol-5-yl)biphenyl-4-yl)-1,3-diazaspiro-4,4 -nonen-4-one
WO2017131218A1 (fr) Azilsartan et son procédé de production
KR101316653B1 (ko) 헤테로고리 화합물의 제조방법
EP2102195A1 (fr) Modifications cristallines de la 3-(1h-indol-3-yl)-4-[2-(4-methyl-piperazin-1-yl) -quinazolin-4-yl]-pyrrole-2,5-d ione
WO2012103105A1 (fr) Procédés de préparation du raltégravir et de ses intermédiaires dans lesdits procédés
EP2152678A1 (fr) Procédé de préparation du valsartan
KR100809159B1 (ko) 로사탄의 개선된 제조방법
US7345071B2 (en) Process for the synthesis of Losartan potassium
JP4437923B2 (ja) トリテルペン誘導体の製造方法
EP2022790A1 (fr) Procédé pour la préparation ou la purification d'olmésartan médoxomil
CN115028589A (zh) 一种阿齐沙坦工艺杂质的制备方法
WO2005066158A2 (fr) Procede ameliore de synthese du losartan potassique
JP2010526126A (ja) バルサルタンの製造方法
ZA200500454B (en) Method for producing highly pure hydroxy indolyl glyoxylic acid amides
JP2001002657A (ja) ２−アルキル−４−クロロ−５−ヒドロキシメチルイミダゾール誘導体の製造法
WO2007020659A2 (fr) Procede de preparation de l'irbesartan forme a

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070123

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20070125

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20070619